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increased immediately after BPA. Both MLD-b and MLD-d further increased at chronic
phase (figure).
Conclusions: BPA achieves beneficial vascular remodeling at distal segment as well as
ballooning site, which is associated with chronic improvement in pulmonary artery
resistance.
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Background: Acute deep venous thrombosis (DVT) responds favorably to various
thrombectomy devices including Trellis (Covidien). In patients with an IVC filter,
occasionally massive bilateral DVT may occur with frequent involvement of the filter.
The role of Trellis in the treatment of IVC filter thrombosis (IVCFT) has not been
investigated.
Methods: Fifty two patients with IVCFT underwent treatment with Trellis as part of the
percutaneous endovenous intervention (PEVI) strategy(Fig.1). All had bilateral lower
extremity and iliac DVT and were quite symptomatic. For initial treatment an 8 F Trellis
system was used in all with administration of 10 mg of tPA via the Trellis catheter. The
device was activated inside the filter.Following the procedure venography was obtained to
assess the outcome.
Results: No patient achieved complete resolution of IVCFT with Trellis thrombectomy
alone. Partial resolution was achieved in only 8 patients. The remaining 44 patients had
no meaningful improvement and required catheter-directed thrombolysis (CDT) with tPA
for a mean duration of 328 hours. With CDT complete or substantial resolution of
IVCFT was achieved. There was no symptomatic pulmonary embolism as a result of
PEVI.
Conclusions: IVCFT is associated with bilateral iliac and femoropopliteal DVT. Trellis
thrombectomy alone has a limited role in its management and most patients require CDT.
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Rapid resolution of right ventricular dysfunction using ultrasonic
thrombolysis in massive and submassive pulmonary embolism patients
Tod Engelhardt1
1East Jefferson General Hospital, Metairie, LA
Background: Acute pulmonary embolism (PE) is a potentially fatal condition. Recent
studies demonstrate support for advanced treatment, especially in patients who present
with systemic hypotension (massive PE) and those who are normotensive but show signs
of RV dysfunction (submassive PE), leading to poor outcomes if inadequately treated.
This study assesses the hemodynamic effects of ultrasound accelerated thrombolysis
(USAT), an emerging catheter-based modality, among these patients in resolving the
thrombus and restoring cardiopulmonary function.
Methods: We retrospectively evaluated consecutive PE patients treated using USAT
(EkoSonic Endovascular System, EKOS Corporation) with recombinant tPA at East
Jefferson General Hospital from 2009 to 2011. All patients presented with signs of acute
PE and received chest CT scans for confirmation of PE. Follow-up CT was performed at
3923 hours after USAT. RV dysfunction was characterized by the right-to-left
ventricular dimension (RV/LV) ratio. Thrombus burden was assessed using the modified
Miller Score. All CT measurements were performed by an independent core laboratory.
Results: Among the 42 patients (age 5816 yrs) evaluated, 7 were massive and 35 were
submassive PE cases. 37 patients (88%) presented with bilateral PE. Overall, the mean
tPA dose was 31.016.6 mg infused over 19.06.8 hours. Following USAT, the RV/LV
ratio was reduced from 1.480.42 to 0.960.18 (p.001) and the modified Miller Score
from 18.05.1 to 9.75.3 (p.001) at follow-up CT. Patients treated early in the series
(n13) using a total dose of45 mg tPA did not show greater reduction in RV/LV ratio
or Miller Score than those later in the series (n29) using a total dose of 20 mg tPA
(p.38). Median length of stay was 1 day in the ICU and 7 days in the hospital. All
patients were discharged alive. There were no systemic bleeding complications, but 4
access site bleeding complications requiring transfusion and 1 suspected recurrent
massive PE event, all reported in the higher tPA dose group.
Conclusions: For massive and submassive PE, treatment by USAT rapidly reduced RV
dilatation and pulmonary clot burden with minimal risk of bleeding, allowing restoration
of cardiopulmonary function.
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Background: Acute high risk pulmonary embolism carries a high degree of morbidity/
mortality and proper and rapid actions must be taken, this study aims to demonstrate how
to recover the patency of the pulmonary arteries by thrombus aspiration with right
coronary guide catheter in order to improve the function of the right ventricle and reduce
mortality.
Methods: A total of 38 patients, 20 female, 18 male, ages 28 to 64 years with high risk
acute pulmonary embolism were studied from March 2009 to April 2012. In all patients
the pulmonary obstruction was bilateral, the degree of obstruction was greater than 80%
of the main branches. The diagnosis was formulated with pulmonary angiotomography
echocardiogram. By percutaneous puncture of the femoral vein an 8 French by 80cm in
length metal sheath was advanced to the trunk of the pulmonary artery, a #4 Judkins right
coronary guide catheter was advanced trough the introducer to the site of thrombosis and
a 20ml syringe connected and vacuum sustained trough the catheter while slowly
withdrawing it, subsequently the catheter was extracted and purged to extract the aspirated
thrombi. This maneuver was repeated several times and finally angiography with this
catheter was perform to confirm the patency of the pulmonary branches.
Results: Extraction of thrombus was achieved in all cases. permeability of the pulmonary
branches was obtained in 80% of the cases, saturation and blood pressure were restored
in the next few hours. One patient (2.63%) died during the procedure and another patient
had hemoptysis.
Conclusions: This is an effective technique for the treatment of high-risk acute
pulmonary embolism reproducible at low-cost and capable to reestablish blood pressure,
oxygen saturation and right ventricular function and decrease morbidity significantly.
TCT-759
Ultrasound-Accelerated Thrombolysis for the Treatment of Acute Pulmonary
Embolism
Matthew Wiisanen1, Joseph Foley1, John Gurley1
1University of Kentucky, Lexington, KY
Background: Acute pulmonary embolism (PE) is a major cause of death. 90-day
mortality rates are 58% for massive PE (with cardiogenic shock) and 22% for submassive
PE (right heart strain without shock). Systemic thrombolysis improves hemodynamic
stability but is associated with major bleeding in 20% of patients. Alternative therapies for
acute PE are needed. This study examines the safety and effectiveness of catheter-directed,
ultrasound-accelerated thrombolysis (USAT) in patients with PE.
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Methods: We retrospectively analyzed data from patients with massive and submassive
PE treated with USAT over a 2-year period. EKOS catheters (EkoSonic Endovascular
system, EKOS Corp., Bothell, WA) were placed in the largest lower lobe pulmonary
artery, bilaterally in 14 patients (93%) and unilaterally in 1 patient (7%). Recombinant
t-PA was administered through the EKOS catheters as a 5 mg bolus followed by 1
mg/hour for a maximum dose of 20 mg.
Results: Fifteen patients received USAT for PE between May, 2010 and April, 2012. Ten
patients (67%) presented with saddle emboli. Four patients (27%) presented with massive
PE requiring inotropic support and mechanical ventilation. Technical success in EKOS
catheter placement was 100%. Pre-USAT echocardiographic RV/LV diameter ratios were
obtained in 13 (87%) patients and were abnormal in 12 (92%) patients (mean 1.23 
0.28). After USAT, 5(33%) patients had follow-up echocardiograms, in which the RV/LV
ratio normalized in all patients (mean 0.83  0.06) (p0.07). Mean pulmonary artery
(PA) pressures were 39.9  2.1 before treatment and 31.2  3.2 after treatment (p  0.03).
Three patients (20%) had follow-up angiography, of which 2 (67%) had complete
resolution of emboli. Mean hospital stay was 10.88.59 days. Thirteen patients
(87%) were discharged alive. One patient (7%) required a blood transfusion.
Conclusions: In patients with massive and submassive PE, USAT restores hemodynamic
stability and reverses right ventricular dilatation and with minimal risk of bleeding
complications.
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Mid-term Outcomes of Alcohol Septal Ablation for Obstructive Hypertrophic
Cardiomyopathy in Patients with Sigmoid versus Neutral Ventricular Septum
Josef Veselka1, Pavol Tomasov1, David Zemanek1
12nd Medical School, Charles University, University Hospital Motol, Prague 5,
Czech Republic
Background: The aim of this study was to determine whether the differences in the baseline
septal morphology influenced outcomes of patients after alcohol septal ablation (ASA).
Methods: A total of 100 consecutive, highly symptomatic patients with HOCM and a neutral
or sigmoid septum (74 patients vs 26 patients) underwent ASA and were examined clinically
and echocardiographically at baseline and at follow-up (median 30 months vs 24 months).
Results: At baseline, a neutral septum morphology was associated with a thicker basal
septum [21 (19-24) mm vs 19 (18-20) mm; p0.01] and higher pressure gradient at rest [59
(39-80) mm vs 43 (33-50) mm; p0.01], but a similar pressure gradient after provocation [100
(72-120) mmHg vs 97 (70-110) mmHg; p0.31], and subsequently both resting gradient [10
(10-16) mmHg vs 12 (10-15) mmHg; p0.67] and provoked gradient after ASA [20 (10-30)
mmHg vs 18 (12-25) mmHg; p0.71]. Four patients died during follow-up (4% vs 1%; NS).
Pressure gradient, septum thickness and symptoms decreased significantly in both groups.
Conclusions: Patients treated with ASA who had a sigmoid septum were characterized
at baseline by a thinner basal septum and lower pressure gradient at rest. However, they
showed an identical pressure gradient after provocation and subsequently after ASA. ASA
was safe and effective in both groups of patients.
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Background: Alcohol septal ablation (ASA) is a catheter-based intervention that has
been used as an alternative to surgical myectomy in highly symptomatic patients with
hypertrophic obstructive cardiomyopathy (HOCM). However, clinically relevant compli-
cations can result, including death and complete heart block (CHB) associated with
syncope or resuscitation.This study was designed to evaluate the incidence of major
complications with a focus on CHB after ASA for HOCM.
Methods: This international, multicenter, retrospective study reviewed 545 patients who
were treated using ASA; 421 (77%) met the inclusion criteria for this study. Clinical and
echocardiographic follow-up (3–6 months) was completed in 394 patients (94%).
Results: ASA led to a significant reduction in symptoms and outflow gradient. One
patient (0.2%) died of cardiac tamponade four days after ASA. Two other patients (0.5%)
died several weeks after ASA (sudden death of unknown cause). Sustained ventricular
arrhythmias occurred within hospital stay in three patients (0.7%). A total of 70 patients
(17%) developed mostly transient intra/post-procedural CHB; in 30% of them, CHB
occurred/reoccurred later than 24 hours after ASA. Ninety-seven percent of CHB
occurred until the fifth post-ASA day. Permanent pacemakers for CHB were implanted in
35 patients (8%). Multivariate analysis identified the intra-procedural bundle branch block
and age as independent predictors of CHB.
Conclusions: In this multicenter study, ASA was clinically effective in highly symp-
tomatic patients undergoing a first intervention for HOCM. The most frequent major
post-procedural complication was CHB (17%) that occurred late or recurred in almost
one-third of these cases (5%). Ninety-seven percent of all CHB cases occurred until the
fifth post-procedural day. Independent predictors of its development were intra-procedural
bundle branch block and age of patients. Difficulties in predicting CHB should lead to
close post-procedural monitoring and hospital stays lasting at least 5 days. Generally,
these results highlight the importance of proper interventional training and establishing
complex “HCM centers” as a prerequisite for all institutions offering ASA.
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Impact of left atrial appendage occlusion, with percutaneous device on left
atrial function
Pedro Almeida1, Eduardo Infante de Oliveira1, João Marques1,
Fernando Ribeiro1, Pedro Canas Silva1, Anto´nio Nunes Diogo1, Fausto Pinto1
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Background: Favorable results with the occlusion of the left atrial appendage (LAA),
using percutaneous devices, for thromboembolic events prevention, has lead to a
widespread use of this technique. However, the long-term effects on left atrial (LA)
function are unclear. The objective of this study was to evaluate the impact of LAA
occlusion on LA function.
Methods: LAA occlusion by percutaneous femoral access was performed in five female
common swine, in sinus rhythm. TEE evaluation of LA dimensions using 2D, mitral and
pulmonary veins (PV) Doppler flow, and TDI of mitral annular motion was performed at
baseline and after 90 days.
Results: Four animals survived until the 90 days. Weight and body surface area increased
from 53.04.7Kg/1.30.1m2 to 74.11.5Kg/1.60.4m2. At basaline, minimum LA
diameter, area and volume were 22.02.1 mm/m2; 5.60.4cm2/m2 and 12.11.1cm3/
m2. Maximum LA diameter, area and volume were 27.63.7mm/m2;7.81.0cm2/m2
and 19.14.0cm3/m2. At 90 days, systolic diameter, area and volume were
19.52.9mm/m2; 5.50.6cm2/m2 and 13.21.4cm3/m2 and diastolic values were
40.15.6mm/m2; 8.91.5cm2/m2 and 27.16.0cm3/m2. LA ejection fraction signifi-
cantly increased from 359% to 507% at 90 days (p0.038). There was a significant
increase in LA maximal diameter (p0.04) and a trend toward LA maximal volume
increase from baseline to follow-up (p0.082). There was a significant increase of E wave
VTI (p0.024) from 7.40.6cm to 10.51.4cm. TDI of mitral annulus showed E‘, A‘
and S‘ basal velocities of 10.82.7cm/s; 8.42.4cm/s and 8.41.6cm/s with no
significant changes to follow-up. The E/E‘ ratio suffered no significant change, and there
was a trend towards peak A‘ wave velocity (p0.067). Baseline PV flow velocities were:
S 65.02.8cm/s; A 31.08.5cm/s and D 51.07.1cm/s. At 90 days, S, A and D, were
55.04.2cm/s; 21.53.5cm/s and 44.56.4cm/s. The S/D ratio was 1.30.1 at baseline
and 1.30.3 at 90 days. The D velocity at follow-up, revealed a significant reduction
relative to the baseline (p0.049).
Conclusions: This study provides initial evidence that LAA occlusion may not significantly
impair LA function and does not lead to armful atrial remodeling or loss of contractile function.
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Safety and Biocompatibility of the Coherex WaveCrestTM Left Atrial
Appendage Occluder in a 30-Day Canine Study
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Background: Left atrial appendage (LAA) occlusion is proposed to reduce the risk of
thromboembolic stroke in atrial fibrillation patients.
Methods: WaveCrestTM (Coherex Medical, Salt Lake City, UT) LAA occluder was
deployed in 6 dogs via transseptal puncture under fluoroscopy and transesophageal
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